{
    "nctId": "NCT05676866",
    "briefTitle": "Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy",
    "officialTitle": "Evaluation of Targeted Axillary Lymph Nodes Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Node-positive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Evaluation the sensitivity of targeted axillary lymph node dissection in node positive breast cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. females with invasive breast cancer with axillary metastasis, staging of n1: n2\n2. complete axillary response to neoadjuvant therapy by clinical examination and imaging\n\nExclusion Criteria:\n\n* 1. breast cancer patients who are not candidate for neoadjuvant chemotherapy 2. breast cancer patients with positive axillary node post neoadjuvant chemotherapy 3. breast cancer patients with distant metastasis 4. patients with axillary lymph node metastasis from another primary tumour \\[not breast cancer\\]",
    "sex": "FEMALE",
    "minimumAge": "15 Years",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}